$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Method of enhancing growth in patients using combination therapy 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-037/36
출원번호 US-0535005 (1990-06-07)
발명자 / 주소
  • Clark Ross G. (Pacifica CA) Cronin Michael J. (San Mateo CA)
출원인 / 주소
  • Genentech, Inc. (South San Francisco CA 02)
인용정보 피인용 횟수 : 68  인용 특허 : 0

초록

A method is disclosed for enhancing growth of a mammal by administration of a combination of effective amounts of IGF-I and GH so as to enhance the growth of the mammal over the enhancement in growth achieved using either IGF-I or GH alone in an amount equal to that used for either IGF-I or GH, resp

대표청구항

A method for enhancing growth of a mammal comprising administering systemically and concurrently to the mammal effective amounts of IGF-I and GH, wherein the GH is administered by injections, so as to enhance said growth of the mammal over the enhancement in growth achieved using an equivalent dose

이 특허를 인용한 특허 (68)

  1. Shirley, Bret A.; Bajwa, Kamaljit, Compositions providing for increased IGF-I solubility.
  2. Shirley, Bret A.; Bajwa, Kamaljit, Compositions providing for increased IGF-I solubility.
  3. Shirley,Bret A.; Bajwa,Kamaljit, Compositions providing for increased IGF-I solubility.
  4. Manning,Anthony M.; Mercurio,Frank; Amit,Sharo; Ben Neriah,Yinon; Davis,Matti; Hatzubai,Ada; Yaron,Avraham; Alkalay,Irit; Ciechanover,Aaron, Compounds and methods for modulating activation of NF-κB.
  5. Manning,Anthony M.; Mercurio,Frank; Amit,Sharo; Ben Neriah,Yinon; Davis,Matti; Hatzubai,Ada; Yaron,Avraham; Alkalay,Irit; Ciechanover,Aaron, Compounds and methods for modulating activation of NF-κB.
  6. Manning, Anthony M.; Mercurio, Frank; Amit, Sharon; Ben-Neriah, Yinon; Davis, Matti; Hatzubai, Ada; Yaron, Avraham; Alkalay, Irit; Ciechanover, Aaron, Compounds and methods for modulating activation of NF-κB.
  7. Schaffer, Michelle; Ultsch, Mark; Vajdos, Felix, Crystallization of IGF-1.
  8. Schaffer,Michelle; Ultsch,Mark; Vajdos,Felix, Crystallization of IGF-1.
  9. Schaffer,Michelle; Ultsch,Mark; Vajdos,Felix, Crystallization of IGF-1.
  10. Schaffer,Michelle; Ultsch,Mark; Vajdos,Felix, Crystallization of IGF-1.
  11. Schaffer,Michelle; Ultsch,Mark; Vajdos,Felix, Crystallization of IGF-1.
  12. Schaffer,Michelle; Ultsch,Mark; Vajdos,Felix, Crystallization of IGF-1.
  13. Mercurio, Frank; Zhu, Hengyi; Barbosa, Miguel; Li, Jian Wu; Murray, Brion W., Double-stranded RNAS directed to IKK-2.
  14. DiPerna, Paul M, Flow regulating stopcocks and related methods.
  15. Sommer Andreas ; Moore Jerome A. ; Adams Steven, High dose IGF-1 therapy.
  16. Barbara H. O'Connor ; James Q. Oeswein, Human growth hormone aqueous formulation.
  17. O'Connor Barbara H. ; Oeswein James Q., Human growth hormone aqueous formulation.
  18. O'Connor Barbara H. ; Oeswein James Q., Human growth hormone aqueous formulation.
  19. Dubaquie, Yves; Fielder, Paul J.; Lowman, Henry B.; Mortensen, Deborah L., IGF-I protein variants for treating IGFBP-1-related disorders.
  20. DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  21. DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  22. Michaud, Michael; Kruse, Geoffrey A., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  23. Michaud, Michael; Kruse, Geoffrey A., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  24. Verhoef, Erik T.; DiPerna, Paul M.; Rosinko, Mike; Williamson, Mark; Kruse, Geoffrey A.; Ulrich, Thomas R.; Lamb, Phil; Saint, Sean; Michaud, Michael; Trevaskis, William, Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  25. Chen, Yvonne Man-yee; Clark, Ross G.; Cochran, Andrea G.; Lowman, Henry B.; Robinson, Iain C. A. F.; Skelton, Nicholas J., Insulin-like growth factor agonist molecules.
  26. Chen, Yvonne Man-yee; Clark, Ross G.; Cochran, Andrea G.; Lowman, Henry B.; Robinson, Iain C. A. F.; Skelton, Nicolas J., Insulin-like growth factor agonist molecules.
  27. Chen, Yvonne Man-yee; Clark, Ross G.; Cochran, Andrea G.; Lowman, Henry B.; Robinson, Iain C. A. F; Skelton, Nicholas J., Insulin-like growth factor agonist molecules.
  28. Clark Ross G. ; Lowman Henry B. ; Robinson Iain C. A. F.,GBX, Insulin-like growth factor agonist molecules.
  29. Clark Ross G.,NZX ; Lowman Henry B. ; Robinson Iain C. A. F.,GBX, Insulin-like growth factor agonist molecules.
  30. Clark, Ross G.; Lowman, Henry B.; Robinson, Iain C. A. F., Insulin-like growth factor agonist molecules.
  31. Clark, Ross G.; Lowman, Henry B.; Robinson, Iain C. A. F., Insulin-like growth factor agonist molecules.
  32. Clark, Ross G.; Lowman, Henry B.; Robinson, Iain C. A. F., Insulin-like growth factor agonist molecules.
  33. Clark, Ross G.; Lowman, Henry B.; Robinson, Iain C. A. F., Insulin-like growth factor agonist molecules.
  34. Clark, Ross G.; Lowman, Henry B.; Robinson, Iain C. A. F., Insulin-like growth factor agonist molecules.
  35. Clark, Ross G.; Lowman, Henry B.; Robinson, Iain C. A. F., Insulin-like growth factor agonist molecules.
  36. Clark, Ross G.; Lowman, Henry B.; Robinson, Iain C. A. F., Insulin-like growth factor agonist molecules.
  37. Clark, Ross G.; Lowman, Henry B.; Robinson, Iain C. A. F., Insulin-like growth factor agonist molecules.
  38. Clark, Ross G.; Lowman, Henry B.; Robinson, Iain C. A. F., Insulin-like growth factor agonist molecules.
  39. Clark, Ross G.; Lowman, Henry B.; Robinson, Iain C. A. F., Insulin-like growth factor agonist molecules.
  40. Clark, Ross G.; Lowman, Henry B.; Robinson, Iain C. A. F., Insulin-like growth factor agonist molecules.
  41. Clark, Ross G.; Lowman, Henry B.; Robinson, Iain C. A. F., Insulin-like growth factor agonist molecules.
  42. Clark, Ross G.; Lowman, Henry B.; Robinson, Iain C. A. F., Insulin-like growth factor agonist molecules.
  43. Clark, Ross G.; Lowman, Henry B.; Robinson, Iain C.A.F., Insulin-like growth factor agonist molecules.
  44. Yvonne Man-yee Chen ; Ross G. Clark NZ; Andrea G. Cochran ; Henry B. Lowman ; Iain C. A. F. Robinson ; Nicholas J. Skelton, Insulin-like growth factor agonist molecules.
  45. Carlsson Lena Mariana Susann,SEX ; Clark Ross Graham ; Wong Wai Lee Tan, Ligand-mediated immunofunctional hormone binding protein assay method.
  46. Clark, Ross Graham; Clark, legal representative, Gillian; Bright, George M.; Liao, Sam, Method and device for diagnosing and treating insulin-like growth factor deficiency disorders.
  47. Shirley, Bret; Hora, Maninder; O'Hagan, Derek; Singh, Manmohan, Method for producing sustained-release formulations.
  48. Chen, Yvonne Man-Yee; Clark, Ross G.; Cochran, Andrea G.; Dubaquie, Yves; Fielder, Paul J.; Filvaroff, Ellen; Lowman, Henry B.; Mortensen, Deborah L.; Robinson, Iain C. A. F.; Skelton, Nicholas J., Method for treating cartilage disorders.
  49. Chen,Yvonne Man Yee; Clark,Ross G.; Cochran,Andrea G.; Dubaquie,Yves; Fielder,Paul J.; Filvaroff,Ellen; Lowman,Henry B.; Mortensen,Deborah L.; Robinson,Iain C. A. F.; Skelton,Nicholas J., Method for treating cartilage disorders.
  50. Clark Ross G. (Pacifica CA), Method for treatment or prevention of obesity.
  51. Clark Ross G. (Pacifica CA) Yeung Douglas A. (Fremont CA) Oeswein James Q. (Moss Beach CA), Method of formulating IGF-I with growth hormone.
  52. Schell Jeff (Koln DEX) Logemann Jurgen (Koln DEX) Jach Guido (Koln DEX) Mundy John (Copenhagen DKX), Method of producing pathogen-resistant plants.
  53. Schell Jeff,DEX ; Logemann Jurgen,DEX ; Jach Guido,DEX ; Mundy John,DKX, Method of producing pathogen-resistant plants.
  54. Clark Ross G. (Pacifica CA), Method of prophylaxis of acute renal failure.
  55. Broderick Carol Lynn ; DiMarchi Richard Dennis ; Heiman Mark Louis ; Stramm Lawrence Edward, Method of treating insulin resistance.
  56. LeBowitz, Jonathan, Methods and compositions for targeting proteins across the blood brain barrier.
  57. Clark, Ross G., Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency.
  58. Clark, Ross G., Methods for treatment of insulin-like growth factor-1 deficiency.
  59. Clark, Ross G.; Clark, legal representative, Gillian, Methods for treatment of insulin-like growth factor-1 deficiency.
  60. Clark, Ross G., Methods of reducing visceral fat by increasing levels of insulin-like growth factor-I (IGF-I).
  61. Bjørn, Søren; Sørensen, Hans Holmegaard; Langballe, Peter; Larsen, Silke Møller; Ebbehøj, Kristen; Hansen, Birthe Lykkegaard, Pharmaceutical formulation.
  62. DiPerna, Paul M., Slideable flow metering devices and related methods.
  63. Brown, David, Solute concentration measurement device and related methods.
  64. Mercurio,Frank; Zhu,Hengyi; Barbosa,Miguel; Li,Jian Wu; Murray,Brion W., Stimulus-inducible protein kinase complex and methods of use therefor.
  65. Rosinko, Michael J.; Kruse, Geoffrey A.; Harris, Paul, System and method for detecting occlusions in an infusion pump.
  66. Metzmaker, Thomas; Saint, Sean; Michaud, Michael; Rosinko, Michael J.; Swanson, Vance, Systems including vial adapter for fluid transfer.
  67. Attie Kenneth ; Carlsson Lena M. S.,SEX ; Gesundheit Neil ; Goddard Audrey, Treatment of partial growth hormone insensitivity syndrome.
  68. DiPerna, Paul M., Two chamber pumps and related methods.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로